Position
Parallel Advisors, LLC in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$5.93K$46.30 → $33.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 448 | $20.7K | — | — | — | 0.0% |
| Q1 2026 | 448 | $14.8K | $33.07 | −$5.93K | $0 | 0.0% |